Accueil>>Signaling Pathways>> Others>> Progesterone Receptor>>Estradiol dipropionate

Estradiol dipropionate

Catalog No.GC60815

Le dipropionate d'estradiol est un œstrogène-progestérone combiné, agit comme un agoniste des œstrogènes et de la progestérone .

Products are for research use only. Not for human use. We do not sell to patients.

Estradiol dipropionate Chemical Structure

Cas No.: 113-38-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
82,00 $US
En stock
5mg
74,00 $US
En stock
10mg
102,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Estradiol dipropionate is a combined estrogen-progesterone, acts as an estrogen and progesterone agonist[1].

Treatment of Estradiol dipropionate (2μg per 100 g; single subcutaneous injection) and Chorionic gonadotropin (10 IU per 100 g; sc; twice a day) for 2 days, levels of β-catenin and GSK-3β in luminal and glandular epithelia are lower in Ovariectomized mice[1].Treatment of Estradiol dipropionate (2 μg per 100 g; once a week) and Chorionic gonadotropin ((10 IU per 100 g; once a day) for a month, the incidence of atypical endometrial hyperplasia is significantly higher, the level of β-catenin is slightly higher, and the expression of GSK-3β is lower in luminal and glandular epithelia[1].

[1]. A G Gunin, et al. Uterine Response to Estradiol Under Action of Chorionic Gonadotropin in Mice. Int J Gynecol Cancer. Jul-Aug 2003;13(4):485-96.

Avis

Review for Estradiol dipropionate

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Estradiol dipropionate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.